These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9278949)

  • 1. Apomorphine induced alteration in corneofundal potentials in depression.
    Demet EM; Albers L; Sokolski KN; Chicz-Demet A; Chen CC; Reist C
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):775-88. PubMed ID: 9278949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.
    McPherson H; Walsh A; Silverstone T
    J Affect Disord; 2003 Sep; 76(1-3):121-5. PubMed ID: 12943941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multihormonal responses to apomorphine in mental illness.
    Mokrani MC; Duval F; Crocq MA; Bailey PE; Macher JP
    Psychoneuroendocrinology; 1995; 20(4):365-75. PubMed ID: 8532820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients.
    Monreal JA; Duval F; Mokrani MC; Fattah S; Palao D
    J Psychiatr Res; 2019 May; 112():18-22. PubMed ID: 30836201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls.
    Pichot W; Hansenne M; Gonzalez Moreno A; Ansseau M
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(6):306-8. PubMed ID: 8527467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
    Meltzer HY; Lee MA; Jayathilake K
    Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
    Pitchot W; Hansenne M; Gonzalez Moreno A; Ansseau M
    Neuropsychobiology; 1995; 32(1):19-22. PubMed ID: 7566518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects.
    Jimerson DC; Cutler NR; Post RM; Rey A; Gold PW; Brown GM; Bunney WE
    Psychiatry Res; 1984 Sep; 13(1):1-12. PubMed ID: 6595680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine measures of dopaminergic function in chronic cocaine users.
    Lee MA; Bowers MM; Nash JF; Meltzer HY
    Psychiatry Res; 1990 Aug; 33(2):151-9. PubMed ID: 2243892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual apomorphine as a neuroendocrine probe.
    Brunerova L; Potockova J; Horacek J; Koprivova H; Rehula M; Andel M
    Psychiatry Res; 2012 Jul; 198(2):297-9. PubMed ID: 22394588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
    Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A
    Biol Psychiatry; 1997 Nov; 42(10):889-97. PubMed ID: 9359974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dopaminergic activity in depressed suicides.
    Pitchot W; Reggers J; Pinto E; Hansenne M; Fuchs S; Pirard S; Ansseau M
    Psychoneuroendocrinology; 2001 Apr; 26(3):331-5. PubMed ID: 11166495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine system challenge in affective disorders: a review of behavioral and neuroendocrine responses.
    Insel TR; Siever LJ
    J Clin Psychopharmacol; 1981 Jul; 1(4):207-13. PubMed ID: 7028802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal pigment epithelium response and the use of the EOG and Arden Ratio in depression.
    Seggie J; MacMillan H; Griffith L; Shannon HS; Martin J; Simpson J; Steiner M
    Psychiatry Res; 1991 Feb; 36(2):175-85. PubMed ID: 2017532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation.
    Brambilla F; Perna G; Bussi R; Bellodi L
    Psychoneuroendocrinology; 2000 Apr; 25(3):301-10. PubMed ID: 10737700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.
    Rotrosen J; Angrist BM; Gershon S; Sachar EJ; Halpern FS
    Psychopharmacology (Berl); 1976 Dec; 51(1):1-7. PubMed ID: 827770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
    Estrella CR; Bregonzio C; Cabrera RJ
    Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tolerance of dopaminergic responses in man.
    Lal S; Thavundayil JX; Ng Ying Kin NM; Dai X; Schwartz G; Montoya A
    J Neural Transm (Vienna); 2008 Aug; 115(8):1189-98. PubMed ID: 18506387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.